Basic Information
Providence Therapeutics is a biotechnology company dedicated to developing a personalized mRNA cancer vaccine aimed at treating ovarian cancer. The company's vaccine can identify tumor mutations and trigger an immune response against tumor cells, enabling users to fully treat themselves. Providence Therapeutics aims to provide effective and safe drugs for patients with unmet medical needs.
Providence Therapeutics Holdings, Inc.
Canada
15~50 people
January 01, 2015
info@providencetherapeutics.com

